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Complex I (NADH:ubiquinone oxidoreductase) is the ﬁrst enzyme
of the respiratory electron transport chain in mitochondria. It
catalyses the reduction of ubiquinone by NADH, coupled to the
translocation of four protons across the inner-mitochondrial mem-
brane, and it is a signiﬁcant source of reactive oxygen species, linked
to neuromuscular diseases and ageing. In bovine mitochondria
complex I comprises 45 different subunits, a ﬂavin mononucleotide
at the active site where NADH is oxidised, and eight iron sulphur
clusters. This talk will focus on the mechanism of the redox reaction
in the enzyme (the mechanism of proton translocation remains
unknown). The structure of the hydrophilic domain of complex I
from Thermus thermophilus has provided a framework for under-
standing the redox reaction, and it makes the pathway that the
electrons take through the enzyme easy to visualise. However, it does
not identify rate limiting steps, or describe the reaction intermediates
formed and the free energy changes as the reaction progresses. A
mechanistic understanding at this level is crucial for understanding
how complex I conserves the potential difference between NADH and
ubiquinone as a proton motive force so effectively, for deﬁning how
electron and proton transfer are coupled, and for understanding the
formation of reactive oxygen species. This talk will describe current
understanding and new information about the mechanism of the
redox reaction in complex I.
doi:10.1016/j.bbabio.2008.05.020
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The molecular mechanism how complex I (NADH:ubiquinone
oxidoreductase) links electron transfer to proton translocation is
still elusive. We have established the strictly aerobic yeast Yarrowia
lipolytica as a powerful genetic system to study structure, function
and biogenesis of this mitochondrial complex I. The ubiquinone
reducing catalytic core of complex I resides at the interface
between the 49-kDa and the PSST subunit of the peripheral arm
where iron–sulfur cluster N2 serves as the immediate reductant of
ubiquinone. In an extensive mutagenesis study based on the
recently published partial structure of bacterial complex I, we
have identiﬁed the entry pathway for ubiquinone and domains
interacting with hydrophobic complex I. Single particle analysis of
antibody decorated complex I indicated that the 49-kDa subunit is
located surprisingly far away from the membrane arm. This
unexpected result was conﬁrmed by further structural studies
with a subcomplex of complex I lacking the 51-kDa and 24-kDa
subunits. Electron microscopic 3D reconstructions of this subcom-
plex allowed positioning the partial structure of the bacterial
complex within Y. lipolytica complex I. Therefore, we propose that
ubiquinone reaches its site of reduction via a hydrophobic ramp or
channel within complex I. We propose a two-state mechanism of
energy conservation for complex I that is based on long range
conformational changes of the enzyme driven by stabilization
changes of ubiquinone intermediates.
doi:10.1016/j.bbabio.2008.05.021
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Mitochondrial diseases are genetically and phenotypically hetero-
geneous. The human mitochondrial DNA (mtDNA) tRNALeu(UUR)
G3243A mutation causes diabetes at low heteroplasmy but MELAS
at high heteroplasmy, the two phenotypes associated with differences
in nuclear DNA (nDNA) and mtDNA gene MITOCHIP gene expression
proﬁles. Inactivation of the mouse heart–muscle–brain isoform of the
adenine nucleotide translocator (Ant1) results in mitochondrial
myopathy and cardiomyopathy associated with defects in mitochon-
drial ADP–ATP exchange and increased mitochondrial reactive oxygen
species (ROS) production. MITOCHIP expression analysis of Ant1-
deﬁcient skeletal muscle revealed the coordinate up-regulation of
mtDNA and nDNA oxidative phosphorylation, antioxidant and anti-
apoptotic genes and the down-regulation of glycolytic and pro-
apoptotic genes, all in association with increased protein levels for
Pgc-1α, Nrf1, myogenin, and Tfam but reduced levels of c-myc.
Neurons from Ant1-deﬁcient mice were more resistant to glutamate
and etoposide induced apoptosis and Ant1-deﬁcient mice were less
sensitive to kainic acid excitotoxicity. Mice harboring a heteroplasmic
mtDNA ND6 frameshift mutation (nt 13885insC) showed directional
loss of the mutant mtDNAs from the female germline in subsequent
liters and generations implying intra-ovarian selection against
severely deleterious mtDNA mutations. By contrast, a COI nt T6589C
missence mutation (V421A) was retained and resulted in the
development of mitochondrial myopathy and cardiomyopathy and
neuronal cell loss. Therefore, mutations in different mitochondrial
genes can produce similar tissue phenotypes, perhaps reﬂecting
similar gene expression proﬁles.
doi:10.1016/j.bbabio.2008.05.022
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We have developed a new method to quantify the transmem-
brane electrochemical proton gradient present in chloroplasts of
dark-adapted leaves. When a leaf is illuminated by a short pulse of
in ten s e l ig h t, we ob se rved that the light-induced membrane
potential change reaches a maximum value (~190 mV) determined
by ion leaks that occur above a threshold level of the electro-
chemical proton gradient. After the light-pulse, the decay of the
membrane potential displays a marked slowdown, which reﬂects
the switch from an activated to an inactivated state of the ATP
synthase that occurs at ~110 mV. We have estimated the Δ
~
µH
+ level
that preexists in the dark (40 to 70 mV), which collapses upon
addition of inhibitors of the respiratory chain. Thus, it shows that it
results from the hydrolysis of ATP of mitochondrial origin.
Illumination of the leaf induces a Δ
~
µH
+ increase (up to ~150 mV)
that reﬂects the light-induced increase in ATP concentration.
Following the illumination, Δ
~
µH
+ relaxes to its dark-adapted value
according to a multiphasic kinetics completed in more than 1 h. In
mature leaf, the deactivation of the Benson–Calvin cycle follows
similar kinetics as Δ
~
µH
+ decay, showing that its state of activation is
mainly controlled by ATP concentration.
doi:10.1016/j.bbabio.2008.05.023
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